Outcome determinants of fusariosis in a tertiary care cancer center: the impact of neutrophil recovery.
about
Recent developments in the management of invasive fungal infections in patients with oncohematological diseasesPosaconazole as Salvage Treatment for Invasive Fusariosis in Patients with Underlying Hematologic Malignancy and Other ConditionsPentamidine is active in a neutropenic murine model of acute invasive pulmonary fusariosisPharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infectionFungal infection of the colonEmerging fungal infections in immunocompromised patients.Time of incubation for antifungal susceptibility testing of Aspergillus fumigatus: can MIC values be obtained at 24 hours?Rare case of disseminated fusariosis in a young patient with graft vs. host disease following an allogeneic transplant.Use of posaconazole in the treatment of invasive fungal infections.Antifungal treatment strategies in patients with haematological diseases or cancer: from prophylaxis to empirical, pre-emptive and targeted therapy.Disseminated amphotericin-resistant fusariosis in acute leukemia patients: report of two cases.Update on the treatment of disseminated fusariosis: Focus on voriconazole.Aspergillus section Fumigati: antifungal susceptibility patterns and sequence-based identification.Hematopoietic stem cell transplantation in a very high risk group of patients with the support of granulocyte transfusion.High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantation.
P2860
Q28077381-11D7FDC3-FF2E-4FE3-8E5E-55D1E9FDA37CQ29399166-95DE0C5A-E004-42EB-9426-FEE315E1CEE0Q34301648-2C2D34C0-E4A5-403C-9199-E033209BAC5CQ34352014-44409247-D41E-4607-BCC1-070BCFB3193BQ34415324-EC84AAB8-7B07-4A57-AE17-A0D7DF7E4DE9Q35161571-EEF470FF-D445-4286-A439-1663AD661F52Q36313161-0C3CCBA6-AC8C-4A2A-B54E-A32EA6A87B3AQ37288342-07600B2A-2651-4082-8DF5-F4835B39D1FAQ37810083-6847BFC0-6122-47A6-8BB3-DA011F01515AQ37873552-4F05246F-03C4-403E-8E64-247DB83773B2Q38053092-F48E5A22-85C0-4440-A3E4-82D415F82F5FQ38536076-62FDFD9B-5AF4-4C7A-AE9C-BEFAC5BB495BQ42112017-A7104385-D9F8-4CA1-AA92-961B2846338CQ42867046-99F26561-2F99-4E37-920B-F46D3BCB3002Q51186226-4ED19D37-C929-40EF-96BF-4BC456BE0EDA
P2860
Outcome determinants of fusariosis in a tertiary care cancer center: the impact of neutrophil recovery.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Outcome determinants of fusari ...... impact of neutrophil recovery.
@en
Outcome determinants of fusari ...... impact of neutrophil recovery.
@nl
type
label
Outcome determinants of fusari ...... impact of neutrophil recovery.
@en
Outcome determinants of fusari ...... impact of neutrophil recovery.
@nl
prefLabel
Outcome determinants of fusari ...... impact of neutrophil recovery.
@en
Outcome determinants of fusari ...... impact of neutrophil recovery.
@nl
P2093
P2860
P1433
P1476
Outcome determinants of fusari ...... impact of neutrophil recovery.
@en
P2093
Girgaway E
Kontoyiannis DP
P2860
P304
P356
10.1080/1042819031000149386
P577
2004-01-01T00:00:00Z